U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
BOCOCIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
bococizumab [INN]
Preferred Name English
Bococizumab [WHO-DD]
Common Name English
PF-04950615
Code English
IMMUNOGLOBULIN G2, ANTI-(HUMAN NEURAL APOPTOSIS-REGULATED PROTEINASE 1) (HUMAN-MUS MUSCULUS MONOCLONAL PF-04950615 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PF-04950615 LIGHT CHAIN, DIMER
Common Name English
BOCOCIZUMAB [USAN]
Common Name English
RN-316
Code English
IMMUNOGLOBULIN G2, ANTI-(HUMAN NEURAL APOPTOSIS-REGULATED PROTEINASE 1)(HUMAN-MUS MUSCULUS MONOCLONAL PF-04950615 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PF-04950615 LIGHT CHAIN, DIMER
Common Name English
BOCOCIZUMAB [JAN]
Common Name English
RN316
Code English
Code System Code Type Description
DRUG BANK
DB12456
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
NCI_THESAURUS
C166723
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
FDA UNII
45M75JVK38
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
USAN
AB-55
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
SMS_ID
100000165896
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
INN
9840
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
ChEMBL
CHEMBL3137349
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
WIKIPEDIA
Bococizumab
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
CAS
1407495-02-6
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
EVMPD
SUB179790
Created by admin on Mon Mar 31 21:28:27 GMT 2025 , Edited by admin on Mon Mar 31 21:28:27 GMT 2025
PRIMARY
ACTIVE MOIETY
BOCOCIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966